iShares Genomics Immunology and Healthcare ETF (IDNA)

Assets	$161.07M
Expense Ratio	0.47%
PE Ratio	14.18
Shares Out	5.45M
Dividend (ttm)	$0.31
Dividend Yield	1.07%
Ex-Dividend Date	Dec 16, 2025
Payout Frequency	Semi-Annual
Payout Ratio	15.18%

Volume	26,041
Open	29.34
Previous Close	29.54
Day's Range	28.76 - 29.40
52-Week Low	19.20
52-Week High	31.41
Beta	0.97
Holdings	64
Inception Date	Jun 11, 2019

About IDNA

Fund Home Page

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: IDNA
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Genomics and Immuno Biopharma Index

Top 10 Holdings

48.27% of assets

Name	Symbol	Weight
Revolution Medicines, Inc.	RVMD	7.10%
Moderna, Inc.	MRNA	6.84%
Ipsen S.A.	IPN	5.16%
Takeda Pharmaceutical Company Limited	4502	4.43%
Exelixis, Inc.	EXEL	4.36%
Bayer Aktiengesellschaft	BAYN	4.35%
Merck & Co., Inc.	MRK	4.30%
Roche Holding AG	ROP	4.00%
GSK plc	GSK	3.97%
Regeneron Pharmaceuticals, Inc.	REGN	3.76%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 16, 2025	$0.15546	Dec 19, 2025
Jun 16, 2025	$0.15291	Jun 20, 2025
Dec 17, 2024	$0.11105	Dec 20, 2024
Jun 11, 2024	$0.11144	Jun 17, 2024
Dec 20, 2023	$0.16925	Dec 27, 2023
Jun 7, 2023	$0.07077	Jun 13, 2023

Performance

IDNA had a total return of 52.60% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.10%.